Open AccessPB1897: DISCONTINUATION OF IMATINIB IN PATIENTS FOLLOWED FOR CHRONIC MYELOID LEUKEMIA IN DEEP MOLECULAR RESPONSE
Author(s) -
Bouchakor Moussa Y.,
Taoussi S.,
Oukid S.,
Lamraoui F.,
Rekab N.,
Benlabiod K. M.,
Brahimi H.,
Abad M. T.,
Bradai M.
Publication year - 2022
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/01.hs9.0000850440.38789.88
Subject(s) - discontinuation , medicine , imatinib , myeloid leukemia , gastroenterology , imatinib mesylate , lymphocytopenia , oncology , lymphocyte